Agios Pharmaceuticals (AGIO) Return on Equity [ROE] (2013 - 2026)
Agios Pharmaceuticals (AGIO) reported Return on Equity [ROE] of -40.47% for Q2 2026, down 84.03 percentage points from 43.56% a year earlier and down 1.50 percentage points from the prior quarter.
Powered by 
Analysis
Agios Pharmaceuticals (AGIO) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025, Agios Pharmaceuticals posted Return on Equity [ROE] of -30.20%, down 87.49 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of +32.76 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at 57.29% in FY2024 (+94.12 pp), -36.83% in FY2023 (-17.46 pp), -19.37% in FY2022 (-209.12 pp) and 189.74% in FY2021 (+252.70 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q2 2024.
- Year over year, Return on Equity [ROE] has now declined in each of the last four quarters, with an average year-over-year change of +2.45 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 193.86 percentage points); the low point was Q1 2022 (a drop of 146.90 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -38.97% (Q1 2026), -35.94% (Q4 2025) and -32.68% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Agios Pharmaceuticals | 1.98 Bn | 1.98 Bn | 41.75 Mn | -40.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.47% |
| Mar 31, 2026 | -38.97% |
| Dec 31, 2025 | -35.94% |
| Sep 30, 2025 | -32.68% |
| Jun 30, 2025 | 43.56% |
| Mar 31, 2025 | 42.49% |
| Dec 31, 2024 | 41.26% |
| Sep 30, 2024 | 57.20% |
| Jun 30, 2024 | -54.85% |
| Mar 31, 2024 | -46.92% |
| Dec 31, 2023 | -41.84% |
| Sep 30, 2023 | -24.07% |
| Jun 30, 2023 | -21.31% |
| Mar 31, 2023 | -20.54% |
| Dec 31, 2022 | -21.55% |
| Sep 30, 2022 | -33.39% |
| Jun 30, 2022 | -31.74% |
| Mar 31, 2022 | -29.16% |
| Dec 31, 2021 | 119.45% |
| Sep 30, 2021 | 102.78% |
API Access
Agios Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AGIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AGIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AGIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();